GoodRx Holdings, Inc.
GDRXFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
792
Cost of Revenue
48
Gross Profit
744
Gross Margin
93.9%
Operating Income
66
Operating Margin
8.3%
Net Income
16
Net Margin
2.1%
EPS (Basic)
$0.04
EPS (Diluted)
$0.04
EBITDA
154
EBITDA Margin
19.4%
2023
12/31/2023
Revenue
750
Cost of Revenue
67
Gross Profit
683
Gross Margin
91.1%
Operating Income
-27
Operating Margin
-3.6%
Net Income
-9
Net Margin
-1.2%
EPS (Basic)
$-0.02
EPS (Diluted)
$-0.02
EBITDA
109
EBITDA Margin
14.5%
2022
12/31/2022
Revenue
767
Cost of Revenue
65
Gross Profit
701
Gross Margin
91.5%
Operating Income
2
Operating Margin
0.2%
Net Income
-33
Net Margin
-4.3%
EPS (Basic)
$-0.08
EPS (Diluted)
$-0.08
EBITDA
65
EBITDA Margin
8.5%
2021
12/31/2021
Revenue
745
Cost of Revenue
47
Gross Profit
699
Gross Margin
93.7%
Operating Income
13
Operating Margin
1.8%
Net Income
-25
Net Margin
-3.4%
EPS (Basic)
$-0.06
EPS (Diluted)
$-0.06
EBITDA
48
EBITDA Margin
6.4%
2020
12/31/2020
Revenue
551
Cost of Revenue
30
Gross Profit
521
Gross Margin
94.6%
Operating Income
-276
Operating Margin
-50.1%
Net Income
-294
Net Margin
-53.3%
EPS (Basic)
$-1.07
EPS (Diluted)
$-1.07
EBITDA
-257
EBITDA Margin
-46.7%